HDAX Therapeutics
Toronto · Founded 2021
About HDAX Therapeutics
HDAX Therapeutics is pioneering next-gen precision therapeutics for cardiovascular and neurological diseases by targeting their root causes to enhance patient outcomes.
Company Facts
- Founded: 2021
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $3.8M
- Funding stage: Seed
- Last round: Seed (Sep 2024)
- Website: https://hdaxtx.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/hdax-therapeutics-75150 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.